This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: L & J Bio Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jeong Kuen Song: Innovator in Alzheimer's Disease Treatment
Introduction
Jeong Kuen Song is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of neuroscience, particularly in the treatment of Alzheimer's disease. His innovative approach focuses on addressing protein deficiencies in the central nervous system.
Latest Patents
Jeong Kuen Song holds a patent for "Methods of decreasing amyloid beta (Aβ) plaque deposition and hyperphosphorylated tau plaque deposition in Alzheimer's disease using a cystatin C fusion protein." This patent outlines a method for treating protein deficiencies by administering a fusion polypeptide that effectively crosses the blood-brain barrier. The fusion polypeptide includes a first protein, a second protein for extended circulation, and a peptide that facilitates crossing the blood-brain barrier.
Career Highlights
Throughout his career, Jeong Kuen Song has been associated with L & J Bio Co., Ltd., where he has worked alongside talented colleagues such as Sookhee Bang and Seung-Wook Shin. His work has been pivotal in advancing therapeutic strategies for neurodegenerative diseases.
Collaborations
Due to space constraints, the details of collaborations will not be included.
Conclusion
Jeong Kuen Song's innovative work in developing treatments for Alzheimer's disease showcases his dedication to improving patient outcomes through scientific advancements. His contributions are vital in the ongoing fight against neurodegenerative disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile